drospirenone has been researched along with Premenstrual Tension in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 35 (76.09) | 29.6817 |
| 2010's | 9 (19.57) | 24.3611 |
| 2020's | 2 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, S; Song, SJ | 1 |
| El Wahed, HAA; Fahim, AS; Hussein, GK; Katta, MA; Moety, GAFA; Shehata, NAA | 1 |
| Caruso, S; Cianci, S; Grillo, C; Maiolino, L; Mauro, D; Rapisarda, AMC | 1 |
| Cheng, W; Fu, Y; Li, L; Mi, W; Sun, L; Wang, J; Xie, S; Zhang, H; Zhang, J | 1 |
| Hayakawa, J; Hayakawa, K; Hiramatsu, K; Koga, S; Kondo, A; Takeda, T; Yaegashi, N | 1 |
| Shehata, NAA | 1 |
| Helmerhorst, FM; Kaptein, AA; Lopez, LM | 3 |
| Mishell, DR | 2 |
| Rapkin, AJ | 1 |
| Short, M | 1 |
| Gricar, J; Rendas-Baum, R; Wallenstein, GV; Yang, M | 1 |
| Giribela, AG; Giribela, CG; Machado, RB; Pompei, Lde M | 1 |
| Heinemann, K; Kunz, M; Marr, J; Rapkin, A | 1 |
| Svojanovská, K | 1 |
| Dickerson, V | 1 |
| Borenstein, J; Chiou, CF; Rapkin, A; Wade, S; Yu, HT | 1 |
| Freeman, EW | 1 |
| Mansour, D | 1 |
| Apter, D; Baumgärtner, W; Borsos, A; Colligs-Hakert, A; Kelly, S; Melis, GB; Palmer, M; Vexiau-Robert, D | 1 |
| Rapkin, A | 1 |
| Sangthawan, M; Taneepanichskul, S | 1 |
| Brown, C; Foegh, M; Pearlstein, TB; Rapkin, A; Sampson-Landers, C; Yonkers, KA | 1 |
| Ylikorkala, O | 1 |
| Foidart, JM | 1 |
| Bachmann, GA; Pearlstein, TB; Yonkers, KA; Zacur, HA | 1 |
| Drezgić, M; Dukić, V; Ivović, M; Penezić, Z; Stojanović, M; Vujović, S; Zidverc, J | 1 |
| Havlín, M | 1 |
| Mikacich, JA; Rapkin, AJ | 1 |
| Kroll, R; Rapkin, AJ | 1 |
| Coffee, AL; Kuehl, TJ; Sulak, PJ; Willis, S | 1 |
| Jaisamrarn, U; Phupong, V; Taneepanichskul, S | 1 |
| Aldrighi, JM; Andrade, RP; Borges, LE; Camargos, AF; Guazelli, C; Isaia, CF; Peixoto, FC; Petracco, A; Yazlle, ME | 1 |
| Rapkin, AJ; Winer, SA | 1 |
| Fenton, C; Moen, MD; Robinson, DM; Wellington, K | 1 |
| Fruzzetti, F; Gambacciani, M; Genazzani, AR; Lazzarini, V; Paoletti, AM; Quirici, B; Ricci, C | 1 |
| Endrikat, J; Fortier, M; Gerlinger, C; Rübig, A; Sandri, M; Schmidt, W | 1 |
| Amarasinghe, AA; Don, CK; Marasinghe, JP | 1 |
| Cianci, A; De Leo, V | 1 |
| Helmerhorst, FM; Kaptein, A; Lopez, LM | 1 |
| Rapkin, AJ; Sorger, SN; Winer, SA | 1 |
| Coffee, AL; Kuehl, TJ; Sulak, PJ | 1 |
| Bouw, GM; Foidart, JM; Gerlinger, C; Heithecker, R; Wuttke, W | 1 |
| Brown, C; Ling, F; Wan, J | 1 |
16 review(s) available for drospirenone and Premenstrual Tension
| Article | Year |
|---|---|
Oral contraceptives containing drospirenone for premenstrual syndrome.
Topics: Contraceptives, Oral, Combined; Drug-Related Side Effects and Adverse Reactions; Estrogens; Female; Humans; Premenstrual Dysphoric Disorder; Premenstrual Syndrome; Progestins | 2023 |
Oral contraceptives containing drospirenone for premenstrual syndrome.
Topics: Androstenes; Contraceptives, Oral, Combined; Female; Humans; Premenstrual Syndrome; Randomized Controlled Trials as Topic | 2009 |
Drospirenone/ethinylestradiol: a review on efficacy and noncontraceptive benefits.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Combined; Dysmenorrhea; Endometrium; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome | 2011 |
Oral contraceptives containing drospirenone for premenstrual syndrome.
Topics: Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Premenstrual Syndrome; Randomized Controlled Trials as Topic | 2012 |
Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone.
Topics: Acne Vulgaris; Androgen Antagonists; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Mineralocorticoids; Premenstrual Syndrome; Progesterone Congeners; Quality of Life; Randomized Controlled Trials as Topic; Weight Gain | 2002 |
Experiences with Yasmin: the acceptability of a novel oral contraceptive and its effect on well-being.
Topics: Adolescent; Adult; Androstenes; Contraception; Contraceptives, Oral, Combined; Female; Humans; Middle Aged; Patient Satisfaction; Pregnancy; Premenstrual Syndrome; Quality of Life; United Kingdom; Women's Health | 2002 |
A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder.
Topics: Androstenes; Contraceptives, Oral; Female; Gonadal Steroid Hormones; Humans; Premenstrual Syndrome | 2003 |
Added benefits of drospirenone for compliance.
Topics: Androstenes; Body Weight; Contraceptives, Oral; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Mineralocorticoid Receptor Antagonists; Patient Compliance; Premenstrual Syndrome; Progesterone Congeners; Quality of Life | 2005 |
[The position of drospirenone in premenstrual syndrome teratment].
Topics: Androstenes; Contraceptive Agents; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome | 2006 |
Premenstrual syndrome in adolescents: diagnosis and treatment.
Topics: Adolescent; Androstenes; Calcium; Female; Humans; Mood Disorders; Patient Education as Topic; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Spironolactone | 2006 |
Treatment of premenstrual disorders.
Topics: Alprazolam; Androstenes; Cognitive Behavioral Therapy; Contraceptives, Oral; Exercise; Female; Gonadotropin-Releasing Hormone; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Spironolactone; Treatment Outcome | 2006 |
Drospirenone: a novel progestin.
Topics: Acne Vulgaris; Androgen Antagonists; Androstenes; Animals; Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Combinations; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Progesterone Congeners | 2007 |
Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome | 2007 |
[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Topics: Androstenes; Contraception; Contraceptives, Oral, Combined; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Evidence-Based Medicine; Female; Humans; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Patient Satisfaction; Practice Guidelines as Topic; Pregnancy; Premenstrual Syndrome; Progesterone; Quality of Life | 2007 |
Oral contraceptives containing drospirenone for premenstrual syndrome.
Topics: Androstenes; Contraceptives, Oral, Combined; Female; Humans; Premenstrual Syndrome; Randomized Controlled Trials as Topic | 2008 |
Drospirenone/ethinyl estradiol.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Premenstrual Syndrome | 2008 |
19 trial(s) available for drospirenone and Premenstrual Tension
| Article | Year |
|---|---|
Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Premenstrual Syndrome; Treatment Outcome | 2020 |
Effects of combined oral contraception containing drospirenone on premenstrual exacerbation of Meniere's disease: Preliminary study.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Disease Progression; Female; Humans; Meniere Disease; Middle Aged; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Young Adult | 2018 |
[Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in the treatment of premenstrual dysphoric disorder: a randomized, double blind placebo-controlled study].
Topics: Androstenes; Contraceptives, Oral; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Menorrhagia; Metrorrhagia; Premenstrual Dysphoric Disorder; Premenstrual Syndrome; Safety; Severity of Illness Index; Treatment Outcome | 2014 |
Effectiveness of ethinylestradiol/drospirenone for premenstrual symptoms in Japanese patients with dysmenorrhea: Open-label pilot study.
Topics: Adult; Androstenes; Drug Therapy, Combination; Dysmenorrhea; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Middle Aged; Mineralocorticoid Receptor Antagonists; Pilot Projects; Premenstrual Syndrome; Prospective Studies; Young Adult | 2015 |
RETRACTED: Calcium versus oral contraceptive pills containing drospirenone for the treatment of mild to moderate premenstrual syndrome: a double blind randomized placebo controlled trial.
Topics: Adult; Androstenes; Calcium; Contraceptives, Oral, Combined; Double-Blind Method; Female; Humans; Premenstrual Syndrome; Severity of Illness Index; Treatment Outcome; Young Adult | 2016 |
Ethinyl estradiol 20μg/drospirenone 3mg 24/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorder.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Premenstrual Syndrome; Psychometrics; Severity of Illness Index; Treatment Outcome | 2011 |
[The efficiency of oral contraception containing drospirenone in treating symptoms of premenstrual syndrome or premenstrual dysphoric disorder in gyneacology practice].
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Hormonal; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Surveys and Questionnaires; Young Adult | 2010 |
Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Multivariate Analysis; Patient Satisfaction; Premenstrual Syndrome; Probability; Reference Values; Severity of Illness Index; Treatment Outcome | 2002 |
A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptoms.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Regression Analysis; Treatment Outcome | 2005 |
Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Estrogens; Ethinyl Estradiol; Female; Humans; Premenstrual Syndrome; Progesterone Congeners; Quality of Life; Treatment Outcome; Uterine Hemorrhage | 2005 |
Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation.
Topics: Adult; Androstenes; Contraceptives, Oral; Cross-Over Studies; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Placebos; Premenstrual Syndrome | 2005 |
Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen.
Topics: Adult; Affect; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2006 |
Efficacy of Yasmin in premenstrual symptoms.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome | 2007 |
Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception.
Topics: Adolescent; Adult; Affect; Androstenes; Blood Pressure; Body Fluids; Body Weight; Contraception; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Premenstrual Syndrome; Progesterone Congeners | 2006 |
Effect of an oral contraceptive containing 30 microg ethinylestradiol plus 3 mg drospirenone on body composition of young women affected by premenstrual syndrome with symptoms of water retention.
Topics: Adult; Androstenes; Body Fluid Compartments; Case-Control Studies; Estrogens; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Prospective Studies | 2007 |
A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight.
Topics: Adult; Androstenes; Body Water; Body Weight; Canada; Contraceptives, Oral, Combined; Edema; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Prospective Studies; Severity of Illness Index; Surveys and Questionnaires | 2007 |
Comparison of scales for evaluating premenstrual symptoms in women using oral contraceptives.
Topics: Adolescent; Adult; Affect; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Surveys and Questionnaires; Weights and Measures | 2008 |
A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel.
Topics: Adult; Androstenes; Body Weight; Contraceptives, Oral, Synthetic; Desogestrel; Europe; Female; Humans; Menstrual Cycle; Menstruation Disturbances; Pregnancy; Pregnancy Rate; Premenstrual Syndrome; Progesterone Congeners | 2000 |
A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Patient Satisfaction; Premenstrual Syndrome; Probability; Treatment Outcome | 2002 |
11 other study(ies) available for drospirenone and Premenstrual Tension
| Article | Year |
|---|---|
Premenstrual syndrome.
Topics: Androstenes; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Randomized Controlled Trials as Topic | 2008 |
An oral contraceptive with 3 approved indications.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Premenstrual Syndrome | 2008 |
YAZ and the novel progestin drospirenone.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Molecular Structure; Patient Satisfaction; Premenstrual Syndrome | 2008 |
YAZ in the treatment of premenstrual dysphoric disorder.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Approval; Ethinyl Estradiol; Female; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors | 2008 |
User satisfaction with the combined oral contraceptive drospirenone 3 mg/ethinylestradiol 20 microg (Yasminelle) in clinical practice: a multi-country, questionnaire-based study.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Drug Combinations; Drug Eruptions; Ethinyl Estradiol; Female; Humans; Ireland; Menstruation; Patient Satisfaction; Premenstrual Syndrome; Surveys and Questionnaires; Weight Gain; Young Adult | 2009 |
Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder.
Topics: Androstenes; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Female; Fluoxetine; Humans; Mineralocorticoid Receptor Antagonists; Models, Economic; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life.
Topics: Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Middle Aged; Patient Satisfaction; Premenstrual Syndrome; Probability; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2003 |
Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms.
Topics: Adolescent; Adult; Androstenes; Contraception; Contraceptives, Oral, Combined; Female; Humans; Middle Aged; Patient Satisfaction; Premenstrual Syndrome; Quality of Life; Women's Health | 2003 |
Drospirenone, a progestin with a unique cardiovascular profile, for safe contraception and treatment of menopausal symptoms.
Topics: Androstenes; Bone Remodeling; Contraceptives, Oral; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Mineralocorticoid Receptor Antagonists; Osteoporosis; Premenstrual Syndrome; Progesterone Congeners | 2005 |
Drospirenone in the treatment of severe premenstrual cerebral edema in a woman with antiphospholipid syndrome, lateral sinus thrombosis, situs inversus and epileptic seizures.
Topics: Abortion, Habitual; Adult; Androstenes; Anticoagulants; Antiphospholipid Syndrome; Brain Edema; Diuretics; Epilepsy; Female; Humans; Intracranial Pressure; Lateral Sinus Thrombosis; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Mutation; Pregnancy; Premenstrual Syndrome; Progesterone; Prolactin; Prothrombin; Situs Inversus | 2005 |
The new extended regimen for the management of premenstrual symptoms needs to be properly assessed.
Topics: Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Premenstrual Syndrome | 2007 |